selected publications
- Treatment Patterns and Healthcare Resource Utilization of Patients With Paroxysmal Nocturnal Hemoglobinuria: A Retrospective Claims Data Analysis. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2024 Academic Article GET IT
- Paroxysmal nocturnal hemoglobinuria: Review of the patient experience and treatment landscape. Blood reviews. 2023 Review GET IT
- Hematological support of patients with significant anemia who decline red blood cell blood transfusion. American journal of hematology. 2022 Letter GET IT
-
Characterization and prognosis of temozolomide-induced aplastic anemia in patients with central nervous system malignancies.
Neuro-oncology.
2022
Academic Article
GET IT
Times cited: 5 -
Hematopoietic Stem-Cell Transplant Utilization in Relapsed/Refractory Hodgkin Lymphoma: A Population-Level Analysis of Statewide Claims Data.
JCO clinical cancer informatics.
2022
Academic Article
GET IT
Times cited: 1 -
Multiorgan failure in a fatal case of autoimmune hemolytic anemia.
2021
GET IT
Times cited: 2 -
Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia.
The New England journal of medicine.
2021
Conference Paper
GET IT
Times cited: 1 -
Iron overload after complement inhibitor treatment of Paroxysmal Nocturnal Hemoglobinuria.
American journal of hematology.
2021
Letter
GET IT
Times cited: 4 -
Implementation and impact of a multidisciplinary coagulation factor stewardship program at an academic medical center.
Journal of thrombosis and thrombolysis.
2020
Letter
GET IT
Times cited: 2 -
COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection.
Blood.
2020
Academic Article
GET IT
Times cited: 921 -
Masitinib in treatment of pancreatic cancer.
Expert opinion on pharmacotherapy.
2018
Academic Article
GET IT
Times cited: 11